Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19928962rdf:typepubmed:Citationlld:pubmed
pubmed-article:19928962lifeskim:mentionsumls-concept:C0004434lld:lifeskim
pubmed-article:19928962lifeskim:mentionsumls-concept:C0005575lld:lifeskim
pubmed-article:19928962lifeskim:mentionsumls-concept:C0053653lld:lifeskim
pubmed-article:19928962lifeskim:mentionsumls-concept:C0022885lld:lifeskim
pubmed-article:19928962lifeskim:mentionsumls-concept:C0392366lld:lifeskim
pubmed-article:19928962lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:19928962lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:19928962lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:19928962lifeskim:mentionsumls-concept:C0439148lld:lifeskim
pubmed-article:19928962lifeskim:mentionsumls-concept:C0683598lld:lifeskim
pubmed-article:19928962lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:19928962lifeskim:mentionsumls-concept:C1527256lld:lifeskim
pubmed-article:19928962lifeskim:mentionsumls-concept:C0206243lld:lifeskim
pubmed-article:19928962lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:19928962lifeskim:mentionsumls-concept:C2347885lld:lifeskim
pubmed-article:19928962lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:19928962pubmed:issue1lld:pubmed
pubmed-article:19928962pubmed:dateCreated2010-1-8lld:pubmed
pubmed-article:19928962pubmed:abstractTextThe synthesis of four biotin derivatives carrying two DOTA moieties for each ligand (BisDOTA set) is reported, for increasing radiation/dose ratio and improving efficiency in the pretargeted avidin-biotin radioimmunotherapy. The biotin-containing scaffold of two BisDOTA was similar to the mono-DOTA derivative previously described. Then the scaffold was elongated by trifunctionalized spacers of different length and conjugated with one of the COOH groups of two DOTA. Two others were prepared starting from a on-resin lysine residue. The lysine alpha-NH2 was bonded to biotin, and then spacers were appended to the epsilon-NH2 and conjugated with two DOTA molecules. One compound contained a p-aminobenzoic acid spacer, which ensured higher head-to-tail distance and increased rigidity of the chain. These last two compounds had a very high ability to bond avidin and were labeled with 90Y at high specific activity. All the compounds were resistant to the action of serum biotinidases.lld:pubmed
pubmed-article:19928962pubmed:languageenglld:pubmed
pubmed-article:19928962pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19928962pubmed:citationSubsetIMlld:pubmed
pubmed-article:19928962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19928962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19928962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19928962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19928962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19928962pubmed:statusMEDLINElld:pubmed
pubmed-article:19928962pubmed:monthJanlld:pubmed
pubmed-article:19928962pubmed:issn1520-4804lld:pubmed
pubmed-article:19928962pubmed:authorpubmed-author:ChinolMarcoMlld:pubmed
pubmed-article:19928962pubmed:authorpubmed-author:PaganelliGiov...lld:pubmed
pubmed-article:19928962pubmed:authorpubmed-author:GinanneschiMa...lld:pubmed
pubmed-article:19928962pubmed:authorpubmed-author:VerdolivaAnto...lld:pubmed
pubmed-article:19928962pubmed:authorpubmed-author:RivieccioVinc...lld:pubmed
pubmed-article:19928962pubmed:authorpubmed-author:PratesiAlessa...lld:pubmed
pubmed-article:19928962pubmed:authorpubmed-author:BucelliFrance...lld:pubmed
pubmed-article:19928962pubmed:authorpubmed-author:MoriIlariaIlld:pubmed
pubmed-article:19928962pubmed:authorpubmed-author:GariboldiLuci...lld:pubmed
pubmed-article:19928962pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19928962pubmed:day14lld:pubmed
pubmed-article:19928962pubmed:volume53lld:pubmed
pubmed-article:19928962pubmed:ownerNLMlld:pubmed
pubmed-article:19928962pubmed:authorsCompleteYlld:pubmed
pubmed-article:19928962pubmed:pagination432-40lld:pubmed
pubmed-article:19928962pubmed:meshHeadingpubmed-meshheading:19928962...lld:pubmed
pubmed-article:19928962pubmed:meshHeadingpubmed-meshheading:19928962...lld:pubmed
pubmed-article:19928962pubmed:meshHeadingpubmed-meshheading:19928962...lld:pubmed
pubmed-article:19928962pubmed:meshHeadingpubmed-meshheading:19928962...lld:pubmed
pubmed-article:19928962pubmed:meshHeadingpubmed-meshheading:19928962...lld:pubmed
pubmed-article:19928962pubmed:meshHeadingpubmed-meshheading:19928962...lld:pubmed
pubmed-article:19928962pubmed:meshHeadingpubmed-meshheading:19928962...lld:pubmed
pubmed-article:19928962pubmed:meshHeadingpubmed-meshheading:19928962...lld:pubmed
pubmed-article:19928962pubmed:meshHeadingpubmed-meshheading:19928962...lld:pubmed
pubmed-article:19928962pubmed:year2010lld:pubmed
pubmed-article:19928962pubmed:articleTitleBiotin derivatives carrying two chelating DOTA units. Synthesis, in vitro evaluation of biotinidases resistance, avidin binding, and radiolabeling tests.lld:pubmed
pubmed-article:19928962pubmed:affiliationLaboratory of Chemistry and Biology of Peptides and Proteins, Department of Organic Chemistry "Ugo Schiff", Via della Lastruccia 13, 50019 Sesto Fiorentino, Firenze, Italy.lld:pubmed
pubmed-article:19928962pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19928962pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:19928962lld:chembl